BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32540998)

  • 1. Upregulation of Proinflammatory Bradykinin Peptides in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Vanarsa K; Henderson J; Soomro S; Qin L; Zhang T; Jordan N; Putterman C; Blanco I; Saxena R; Mohan C
    J Immunol; 2020 Jul; 205(2):369-376. PubMed ID: 32540998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue].
    Stanislav ML; Balabanova RM; Alekperov RT; Miagkova MA; Abramenko TV; Kiselev IP; Kost OA; Nikol'skaia II; Garats EV
    Ter Arkh; 2001; 73(5):20-5. PubMed ID: 11517741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
    Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R; Sturfelt G; Nived O; Wieslander J
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.
    Bartsch YC; Rahmöller J; Mertes MMM; Eiglmeier S; Lorenz FKM; Stoehr AD; Braumann D; Lorenz AK; Winkler A; Lilienthal GM; Petry J; Hobusch J; Steinhaus M; Hess C; Holecska V; Schoen CT; Oefner CM; Leliavski A; Blanchard V; Ehlers M
    Front Immunol; 2018; 9():1183. PubMed ID: 29928274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
    Li B; Yue Y; Dong C; Shi Y; Xiong S
    Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.
    Witte T; Hartung K; Sachse C; Matthias T; Fricke M; Deicher H; Kalden JR; Lakomek HJ; Peter HH; Schmidt RE
    Rheumatol Int; 1998; 18(3):85-91. PubMed ID: 9833247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
    Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
    Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the activity of immunoglobulin G and therapeutic preparations of normal human immunoglobulin in patients with systemic lupus erythematosus and rheumatoid arthritis and in healthy persons].
    Speranskiĭ AI; Nasonova VA; Riazantseva TA; Ivanova SM; Melkumova KL
    Revmatologiia (Mosk); 1991; (1):22-4. PubMed ID: 1712506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
    Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
    Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoB blockade selectively inhibits autoantibody production in autoimmune models of rheumatoid arthritis and lupus.
    Mandik-Nayak L; DuHadaway JB; Mulgrew J; Pigott E; Manley K; Sedano S; Prendergast GC; Laury-Kleintop LD
    Dis Model Mech; 2017 Nov; 10(11):1313-1322. PubMed ID: 28882929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    Chapman EA; Lyon M; Simpson D; Mason D; Beynon RJ; Moots RJ; Wright HL
    Front Immunol; 2019; 10():423. PubMed ID: 30915077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.